Navigation Links
MedeAnalytics Introduces New Provider Engagement Solution at AHIP Institute 2013
Date:6/12/2013

LAS VEGAS, June 12, 2013 /PRNewswire/ -- Today MedeAnalytics, a leading provider of healthcare performance management solutions, introduced its new Provider Engagement solution, a dynamic tool that helps improve operational efficiency for health plans and hospitals, and positions health plans to successfully participate in the Affordable Care Act's (ACA) permanent risk adjustment program for qualified health plans' individual and small group members, both inside and outside health insurance exchanges. The solution was introduced at America's Health Insurance Plans (AHIP) Institute 2013 in Las Vegas, Nev.

(Logo:  http://photos.prnewswire.com/prnh/20100621/SF23660LOGO)

Powerful Marketplace Advantage
"By enabling financial and operational transparency, MedeAnalytics' Provider Engagement solution helps improve communication between health plans and providers," said Michelle Sieling, MedeAnalytics' senior director of product marketing. "The solution addresses providers' and health plans' need to have a view into the claims life cycle, risk scores, and management of value-based contracts. Bottom line, it creates a powerful marketplace advantage that sets the foundation for improved operational efficiency and successful participation in the ACA's permanent risk adjustment program." Sieling noted that the solution calculates and predicts the risk score for ACA permanent risk adjustment program populations by using the federally certified risk adjustment methodology or the alternative certified risk adjustment model chosen by a state health insurance exchange and Medicare Advantage.

ACA Risk Adjustment Program Participation: Solution's Core Drivers of Value

  • Fully integrated and data-driven provider engagement analytics and reporting solution to support Medicaid, Medicare Advantage and commercial populations
  • Ability to monitor, analyze and report HHS-adjusted risk scores
  • Standard solution that is highly adaptable, with rapid development cycles that can be tailored to any state-approved model
  • Collaboration between the health plan and providers through online analytics and reporting to support provider engagement regarding HHS risk scores, operational transparency, and management of value-based contracts

Provider Engagement Solution Supports Value-Based Contracting
MedeAnalytics' Provider Engagement solution enables payment modeling to support risk-, performance- and administrative-based programs. Provider performance analytics evaluates providers according to their cost, quality and efficiency. Population health management enables the promotion of evidence-based medicine, patient engagement, and care coordination with providers. These analyses enable network management business staff to design narrow networks, assess provider quality and efficiency, design and monitor pay-for-performance initiatives, and support accountable care.

About MedeAnalytics
Founded in 1994, MedeAnalytics delivers performance management solutions across the healthcare system—including hospitals, physician practices and payers—to ensure accountability and improve financial, operational and clinical outcomes. For more information, visit www.medeanalytics.com.

For more information:
Gary Summers
Lewis & Summers Public Relations
(925) 954-8187
gary@prwebsite.com

 

 


'/>"/>
SOURCE MedeAnalytics
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. MedeAnalytics Ken Perez Predicts Rapid Growth of Healthcare Data Analytics Market at Conference on Data Analytics in Life Sciences, Healthcare and Biotech Companies
2. Alpha Technics Introduces the t-Pod™ Temperature Measurement System
3. NDA Partners Introduces New Premier Expert Consultants
4. Clinverse, Inc. Introduces ClinSpend to Meet Challenges of Sunshine Act Reporting Requirements
5. DNA2.0 Introduces Simple, IP-Free©, Scarless Cloning
6. Rigaku Introduces the Fastest 1D Detector for XRD Analysis
7. Allegheny General Hospital Cardiovascular Team Introduces New MRI Capability for Patients with Pacemakers, Implantable Defibrillators
8. Watlow Introduces Its New Industrial Heater Catalog
9. RURO Introduces ezColony 4.1 – The Versatile Transgenic Animal Colony Management Software
10. INTIO Introduces TipTRAC™, its Newest Feature for its ClearStart SVM™ Intraoperative Imaging System
11. SeraCare Introduces New Hepatitis C ACCUVERT Seroconversion Panels and Anti-Herpes ACCUSET Performance Panel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... ... , ... The Society for Immunotherapy of Cancer (SITC) strongly opposes the proposed ... fiscal year 2018 budget request. , This proposal calls for a ... roughly 20% of its total budget. If applied proportionally across NIH, funding for the ...
(Date:3/22/2017)... , March 22, 2017  RXi Pharmaceuticals ... innovative therapeutics that address significant unmet medical needs, ... Chief Business Officer, will present at the 5th ... will provide a platform to present to and ... leading pharmaceutical and biotech companies as well as ...
(Date:3/20/2017)... ... March 20, 2017 , ... ... and biotech companies, recently announced it will debut a brand new pressure vessel, ... The intelliVessel is controlled by a touch screen panel and features other revolutionary ...
(Date:3/20/2017)... , ... March 20, 2017 , ... The fourth annual ... while innovating to make an extraordinary impact on peoples’ lives, launches today. Sponsored by ... challenge every 5 weeks and awards thousands in cash prizes to engineers, inventors and ...
Breaking Biology Technology:
(Date:2/14/2017)... N.C. , Feb. 14, 2017  Wake Forest ... M.D., as its new chief executive officer (CEO). Freischlag ... CEO John D. McConnell , M.D., who last ... position at the Medical Center, after leading it since ... the full scope of Wake Forest Baptist,s academic health ...
(Date:2/10/2017)... Feb 10, 2017 Research and ... "Personalized Medicine - Scientific and Commercial Aspects" to ... ... Diagnosis is integrated with therapy for selection of treatment as ... detection and prevention of disease in modern medicine. Biochip/microarray technologies ...
(Date:2/8/2017)... 2017  Aware, Inc. (NASDAQ: AWRE ), a ... results for its quarter and year ended December 31, 2016. ... was $3.9 million compared to $6.9 million in the same ... 2016 was $0.6 million compared to $2.6 million in the ... of 2016 was $0.5 million, or $0.02 per diluted share, ...
Breaking Biology News(10 mins):